| Literature DB >> 24131926 |
Dipali A Date1, Amy C Burrows1, Monica Venere2, Mark W Jackson3, Matthew K Summers4.
Abstract
p31(Comet) is a well-known interacting partner of the spindle assembly checkpoint (SAC) effector molecule Mad2. At the molecular level it is well established that p31(Comet) promotes efficient mitotic exit, specifically the metaphase-anaphase transition, by antagonizing Mad2 function. However, there is little knowledge of how p31(Comet) is regulated or the physiological importance of controlling p31(Comet). Here, we show that the Rb-E2F pathway regulates p31(Comet) expression. In multiple tumor types (including breast and lung) p31(Comet) expression is increased along with Mad2. Expression of this antagonist-target pair is coordinated in cells and correlated in cancer. Moreover, a narrow range of p31(Comet):Mad2 ratios is compatible with cellular viability. Our data suggest that coordinate regulation is important for the outgrowth of oncogenic cell populations. Our findings suggest that altered p31(Comet):Mad2 expression ratios may provide new insight into altered SAC function and the generation of chromosomal instability in tumors.Entities:
Keywords: E2F; Mad2; Rb; cancer; cell cycle; p31Comet; spindle assembly checkpoint
Mesh:
Substances:
Year: 2013 PMID: 24131926 PMCID: PMC3905074 DOI: 10.4161/cc.26811
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 4.534